Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single versus dual antioxidants as adjuvant treatment in acute aluminum phosphide poisoning
PACTR202503804578932Phase 2Not yet recruiting
- Sponsor
- Tanta University Hospitals
- Start
- Sep 2025
- Countries
- 1
01
Overview
Phase 2, open-label trial in Aluminium phosphide poisoning (2 arms), sponsored by Tanta University Hospitals. Primary endpoint: In-hospital mortality. Planned start Sep 2025; status: not yet recruiting.
02
Conditions
Aluminium phosphide poisoning
Beyond the preview
Go deeper on PACTR202503804578932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503804578932.